Zantac Ordered Off Store Shelves Over Cancer Risks

FDA mandates halt to distribution of ranitidine (Zantac) due to potentially carcinogenic contamination After previously warning consumers and doctors last September that it had found measurable amounts of the carcinogen NDMA (N-notrisodimethylamine) in samples of the widely-used heartburn medication Zantac, the U.S. Food and Drug Administration has now ordered manufacturers to immediately stop distributing all